This is a direct violation of 503A compounding laws
Food and Drug Administration (FDA) for medical, diagnostic, or therapeutic use
Check the due-today amount, cancellation window, refund policy, renewal date, and what happens if you stop treatment before the term ends
In this study, measurements of DXA revealed that total fat mass percentage and android/ginoid ratio decreased with liraglutide 3.0 mg/day compared with placebo
GLP-1 is the same gut hormone targeted by semaglutide (Ozempic) medications it slows gastric emptying, reduces appetite, and improves insulin sensitivity
Trial evidence for tirzepatide Tirzepatide's weight-management evidence comes chiefly from the SURMOUNT program, published in The New England Journal of Medicine in 2022, with SURMOUNT-OSA extending to obstructive sleep apnea in 2024